Genetic Technologies
GENE
#10485
Rank
ยฃ2.78 M
Marketcap
ยฃ0.57
Share price
0.00%
Change (1 day)
-70.01%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : ยฃ0.43 Million

According to Genetic Technologies's latest financial reports the company's total debt is ยฃ0.43 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30ยฃ0.46 M66.9%
2023-06-30ยฃ0.27 M-24.84%
2022-06-30ยฃ0.36 M233.03%
2021-06-30ยฃ0.11 M-58.52%
2020-06-30ยฃ0.26 M
2019-06-30N/A
2015-06-30ยฃ0.01 M-99.11%
2014-06-30ยฃ1.37 M
2013-06-30N/A-100%
2012-06-30ยฃ0.01 M-74.38%
2011-06-30ยฃ0.04 M-78.69%
2010-06-30ยฃ0.21 M16.18%
2009-06-30ยฃ0.18 M27.3%
2008-06-30ยฃ0.14 M-35.22%
2007-06-30ยฃ0.22 M-67.59%
2006-06-30ยฃ0.68 M-22.37%
2005-06-30ยฃ0.88 M233.47%
2004-06-30ยฃ0.26 M-6.44%
2003-06-30ยฃ0.28 M
2002-06-30N/A-100%
2001-06-30ยฃ0.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
ยฃ0.41 M-5.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
ยฃ0.15 B 36,143.27%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ4.89 B 1,114,666.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ4.78 B 1,089,417.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ2.21 M 402.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
ยฃ12.64 B 2,877,509.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ26.76 B 6,091,090.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
ยฃ0.59 B 135,198.52%๐Ÿ‡บ๐Ÿ‡ธ USA